Annual SGA
$25.68 M
+$1.40 M+5.75%
December 31, 2023
Summary
- As of February 7, 2025, SLN annual SGA is $25.68 million, with the most recent change of +$1.40 million (+5.75%) on December 31, 2023.
- During the last 3 years, SLN annual SGA has risen by +$7.73 million (+43.08%).
- SLN annual SGA is now -6.71% below its all-time high of $27.53 million, reached on December 31, 2021.
Performance
SLN SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$7.29 M
+$615.10 K+9.22%
September 1, 2024
Summary
- As of February 7, 2025, SLN quarterly SGA is $7.29 million, with the most recent change of +$615.10 thousand (+9.22%) on September 1, 2024.
- Over the past year, SLN quarterly SGA has increased by +$2.18 million (+42.58%).
- SLN quarterly SGA is now -10.30% below its all-time high of $8.12 million, reached on December 31, 2020.
Performance
SLN Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$1.64 B
-$109.32 M-7.13%
September 1, 2024
Summary
- As of February 7, 2025, SLN TTM SGA is -$1.64 billion, with the most recent change of -$109.32 million (-7.13%) on September 1, 2024.
- Over the past year, SLN TTM SGA has dropped by -$1.67 billion (-6510.07%).
- SLN TTM SGA is now -6873.03% below its all-time high of -$23.56 million.
Performance
SLN TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
SLN Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +5.8% | +42.6% | -6510.1% |
| 3 y3 years | +43.1% | +78.7% | -6835.7% |
| 5 y5 years | +77.7% | +78.7% | -6835.7% |
SLN Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -6.7% | +5.8% | -7.0% | +78.7% | -88.9% | at low |
| 5 y | 5-year | -6.7% | +108.6% | -10.3% | +111.5% | -334.2% | at low |
| alltime | all time | -6.7% | >+9999.0% | -10.3% | +111.5% | -6873.0% | at low |
Silence Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $7.29 M(+9.2%) | $25.63 M(+4.1%) |
| Jun 2024 | - | $6.67 M(+1.7%) | $24.62 M(+1.1%) |
| Mar 2024 | - | $6.56 M(+28.3%) | $24.35 M(-5.0%) |
| Dec 2023 | $25.68 M(+5.7%) | $5.11 M(-18.6%) | $25.63 M(+4.2%) |
| Sep 2023 | - | $6.28 M(-2.0%) | $24.60 M(-2.3%) |
| Jun 2023 | - | $6.40 M(-18.3%) | $25.18 M(+2.8%) |
| Mar 2023 | - | $7.84 M(+92.3%) | $24.49 M(+0.4%) |
| Dec 2022 | $24.28 M(-11.8%) | $4.08 M(-40.5%) | $24.39 M(-11.7%) |
| Sep 2022 | - | $6.86 M(+19.9%) | $27.61 M(-2.4%) |
| Jun 2022 | - | $5.72 M(-26.1%) | $28.29 M(-6.0%) |
| Mar 2022 | - | $7.74 M(+6.1%) | $30.09 M(+9.3%) |
| Dec 2021 | $27.53 M(+53.4%) | $7.29 M(-3.3%) | $27.52 M(-2.9%) |
| Sep 2021 | - | $7.54 M(+0.4%) | $28.35 M(+16.9%) |
| Jun 2021 | - | $7.52 M(+45.4%) | $24.25 M(+44.9%) |
| Mar 2021 | - | $5.17 M(-36.4%) | $16.74 M(+44.7%) |
| Dec 2020 | $17.95 M(+45.8%) | $8.12 M(+135.8%) | $11.57 M(+235.8%) |
| Sep 2020 | - | $3.45 M | $3.45 M |
| Dec 2019 | $12.31 M(-14.8%) | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | $14.45 M(+73.1%) | - | - |
| Dec 2017 | $8.35 M(+55.4%) | - | - |
| Dec 2016 | $5.37 M(+32.4%) | - | - |
| Dec 2015 | $4.06 M(-24.4%) | - | - |
| Dec 2014 | $5.37 M(-3.1%) | - | - |
| Dec 2013 | $5.54 M(+33.8%) | - | - |
| Dec 2012 | $4.14 M(-2.4%) | - | - |
| Dec 2011 | $4.24 M(+404.3%) | - | - |
| Dec 2010 | $841.70 K(+81.6%) | - | - |
| Dec 2009 | $463.60 K(+78.2%) | - | - |
| Dec 2007 | $260.20 K(-18.9%) | - | - |
| Dec 2006 | $320.80 K(+1.3%) | - | - |
| Dec 2005 | $316.60 K(-72.1%) | - | - |
| Dec 2004 | $1.14 M(+260.1%) | - | - |
| Dec 2003 | $315.60 K(+69.3%) | - | - |
| Dec 2002 | $186.40 K(+33.4%) | - | - |
| Dec 2001 | $139.70 K(+16.7%) | - | - |
| Dec 2000 | $119.70 K | - | - |
FAQ
- What is Silence Therapeutics annual SGA?
- What is the all time high annual SGA for Silence Therapeutics?
- What is Silence Therapeutics annual SGA year-on-year change?
- What is Silence Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for Silence Therapeutics?
- What is Silence Therapeutics quarterly SGA year-on-year change?
- What is Silence Therapeutics TTM SGA?
- What is the all time high TTM SGA for Silence Therapeutics?
- What is Silence Therapeutics TTM SGA year-on-year change?
What is Silence Therapeutics annual SGA?
The current annual SGA of SLN is $25.68 M
What is the all time high annual SGA for Silence Therapeutics?
Silence Therapeutics all-time high annual SGA is $27.53 M
What is Silence Therapeutics annual SGA year-on-year change?
Over the past year, SLN annual SGA has changed by +$1.40 M (+5.75%)
What is Silence Therapeutics quarterly SGA?
The current quarterly SGA of SLN is $7.29 M
What is the all time high quarterly SGA for Silence Therapeutics?
Silence Therapeutics all-time high quarterly SGA is $8.12 M
What is Silence Therapeutics quarterly SGA year-on-year change?
Over the past year, SLN quarterly SGA has changed by +$2.18 M (+42.58%)
What is Silence Therapeutics TTM SGA?
The current TTM SGA of SLN is -$1.64 B
What is the all time high TTM SGA for Silence Therapeutics?
Silence Therapeutics all-time high TTM SGA is -$23.56 M
What is Silence Therapeutics TTM SGA year-on-year change?
Over the past year, SLN TTM SGA has changed by -$1.67 B (-6510.07%)